Biotech Startups: How to Succeed in a COVID-19 World

Authors: Suzanne Elvidge , Dr. Oded Ben-Joseph (contributing author)

Navigating uncharted waters, biotech investors, executives and entrepreneurs are finding unique challenges (and opportunities) in a COVID-19 world. Contributing author, Outcome Capital’s Dr. Oded Ben-Joseph, Managing Director and Co-Founder of the Life Sciences Practice.

View PDF

News November 12, 2021

Outcome Capital Announces Getinge Has Acquired Verrix

November 12, 2021 10:48 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a specialized life sciences and healthcare advisory and investment banking firm, today announced that Getinge has acquired Verrix LLC. Outcome Capital served as the exclusive strategic and financial advisor to Verrix. “There is a growing demand for biological indicators from healthcare institutions around the […]

Outcome Capital Congratulates Dr. Ellen Baron for the AbCellera Acquisition of TetraGenetics

September 13, 2021 Vancouver, British Columbia & Boston, MA. AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced it has acquired TetraGenetics, Inc. (TetraGenetics), a biotechnology company with a proprietary platform for generating recombinant human ion channels and other transmembrane proteins, in an all-cash transaction that includes […]

Outcome Capital Life Sciences Pulse

Outcome Capital Life Science Market Pulse October 2021 Click to view our LifeSciences Pulse Newsletter

Download

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Biotech Startups: How to Succeed in a COVID-19 World

Navigating uncharted waters, biotech investors, executives and entrepreneurs are finding unique challenges (and opportunities) in a COVID-19 world. Contributing author, Outcome Capital’s Dr. Oded Ben-Joseph, Managing Director and Co-Founder of the Life Sciences Practice.